Tenet Healthcare Corporation $THC Stock Acquired by Signaturefd LLC

Signaturefd LLC raised its stake in Tenet Healthcare Corporation (NYSE:THC) by 269.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,819 shares of the company’s stock after buying an additional 2,057 shares during the period. Signaturefd LLC’s holdings in Tenet Healthcare were worth $720,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in THC. PeakShares LLC grew its position in Tenet Healthcare by 3.3% in the first quarter. PeakShares LLC now owns 1,693 shares of the company’s stock worth $319,000 after acquiring an additional 54 shares in the last quarter. Sanctuary Advisors LLC raised its position in Tenet Healthcare by 0.5% during the first quarter. Sanctuary Advisors LLC now owns 11,900 shares of the company’s stock valued at $2,246,000 after purchasing an additional 57 shares in the last quarter. Applied Finance Capital Management LLC lifted its stake in Tenet Healthcare by 3.8% during the first quarter. Applied Finance Capital Management LLC now owns 1,644 shares of the company’s stock worth $310,000 after purchasing an additional 60 shares during the last quarter. Mather Group LLC. boosted its holdings in shares of Tenet Healthcare by 126.9% in the 3rd quarter. Mather Group LLC. now owns 118 shares of the company’s stock worth $30,000 after purchasing an additional 66 shares in the last quarter. Finally, Davidson Capital Management Inc. boosted its holdings in shares of Tenet Healthcare by 1.0% in the 3rd quarter. Davidson Capital Management Inc. now owns 6,712 shares of the company’s stock worth $1,715,000 after purchasing an additional 67 shares in the last quarter. 95.44% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of brokerages recently weighed in on THC. TD Cowen raised their price objective on Tenet Healthcare from $233.00 to $263.00 and gave the company a “buy” rating in a report on Monday, July 27th. Zacks Research lowered Tenet Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 29th. Barclays increased their price target on shares of Tenet Healthcare from $240.00 to $271.00 and gave the company an “overweight” rating in a research report on Friday, July 24th. Mizuho set a $290.00 price target on shares of Tenet Healthcare in a research note on Monday, August 10th. Finally, Wells Fargo & Company boosted their price objective on shares of Tenet Healthcare from $231.00 to $281.00 and gave the stock an “overweight” rating in a report on Monday, August 3rd. Eighteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $280.21.

Tenet Healthcare Trading Up 2.2%

NYSE THC opened at $267.75 on Thursday. Tenet Healthcare Corporation has a 1-year low of $157.58 and a 1-year high of $283.05. The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00. The stock has a 50-day moving average of $264.84 and a 200-day moving average of $219.63. The firm has a market cap of $21.56 billion, a PE ratio of 10.33, a price-to-earnings-growth ratio of 1.02 and a beta of 1.20.

Insiders Place Their Bets

In other Tenet Healthcare news, EVP Lisa Foo sold 24,000 shares of Tenet Healthcare stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $266.32, for a total value of $6,391,680.00. Following the transaction, the executive vice president directly owned 8,053 shares of the company’s stock, valued at $2,144,674.96. The trade was a 74.88% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Tammy Romo sold 4,922 shares of the business’s stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $264.15, for a total value of $1,300,146.30. Following the completion of the sale, the director owned 30,784 shares of the company’s stock, valued at $8,131,593.60. The trade was a 13.78% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 106,484 shares of company stock worth $28,898,063. 0.97% of the stock is currently owned by corporate insiders.

About Tenet Healthcare

Tenet Healthcare Corp. (NYSE: THC) is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.

Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.